0
     

Report Added
Report already added
Clinical Decision Support System (CDSS) Market in United States 2022 - Industry Briefing

Clinical Decision Support System (CDSS) Market in United States 2022 - Industry Briefing

Clinical decision support systems (CDSS) are computer-based programs that analyze data within EHRs to provide prompts and reminders to assist health care providers in implementing evidence-based clinical guidelines at the point of care. Garnering a CAGR of 8.9% from 2022 to 2028, the clinical decision support system market in United States is projected to reach worth of USD 7,244 million by 2028-end, according to a new report by Gen Consulting Company.

This industry report offers market estimates of the United States market, followed by a detailed analysis of the product type, mode of advice, model, application, and end user. The United States market data on clinical decision support system can be segmented by product type: integrated, standalone. Clinical decision support system market is further segmented by mode of advice: passive, active. Based on model, the clinical decision support system market is segmented into: knowledge-based, non-knowledge based. On the basis of application, the clinical decision support system market also can be divided into: decision delivery, decision workflow, decision analytics, decision evidence. The decision delivery segment is estimated to account for the largest share of the clinical decision support system market in United States. Clinical decision support system market by end user is categorized into: hospitals and clinics, ASCs, others.

The United States clinical decision support system market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Allscripts Healthcare Solutions Inc., athenahealth Inc., Change Healthcare Inc., EBSCO Industries Inc., eClinicalWorks LLC, Elsevier Plc (RELX Plc), Epic Systems Corporation, Flatiron Health Inc., HCA Healthcare Inc., Hearst Communications Inc., International Business Machines Corporation, Koninklijke Philips N.V., Oracle Corporation, Symphony Performance Health Inc., Wolters Kluwer N.V.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
- Get a detailed picture of the United States Clinical Decision Support System Market
- Identify segments/areas to invest in over the forecast period in the United States Clinical Decision Support System Market
- Understand the competitive environment, the market’s leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS

Part 1. Summary
Part 2. Introduction
· Study period
· Geographical scope
· Market segmentation
Part 3. Clinical decision support system market overview
Part 4. Market breakdown by product type
· Integrated
· Standalone
Part 5. Market breakdown by mode of advice
· Passive
· Active
Part 6. Market breakdown by model
· Knowledge-based
· Non-knowledge based
Part 7. Market breakdown by application
· Decision delivery
· Decision workflow
· Decision analytics
· Decision evidence
Part 8. Market breakdown by end user
· Hospitals and clinics
· ASCs
· Others
Part 9. Key companies
· Allscripts Healthcare Solutions, Inc.
· athenahealth Inc.
· Change Healthcare Inc.
· EBSCO Industries Inc.
· eClinicalWorks, LLC
· Elsevier Plc (RELX Plc)
· Epic Systems Corporation
· Flatiron Health, Inc.
· HCA Healthcare, Inc.
· Hearst Communications, Inc.
· International Business Machines Corporation
· Koninklijke Philips N.V.
· Oracle Corporation
· Symphony Performance Health, Inc.
· Wolters Kluwer N.V.
Part 10. Methodology

Report Title: Clinical Decision Support System (CDSS) Market in United States 2022 - Industry Briefing


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline